Genomics Market worth $83.1 billion by 2028 Download PDF Brochure:-https://lnkd.in/duhBQxjx The global genomics market in terms of revenue was estimated to be worth $46.2 billion in 2023 and is poised to reach $83.1 billion by 2028, growing at a CAGR of 12.4% from 2023 to 2028. The prominent genomics product and service providers are Illumina, Inc. (US), Thermo Fisher Scientific, (US), Danaher Corporation (US), QIAGEN (Germany), Agilent Technologies, (US), and PerkinElmer Inc. (US). #genomics #ngs #genome #biotechnology
Snehal Gupta’s Post
More Relevant Posts
-
Medical Laboratory Scientist | MSc in BioChem & BioTech (Reading) | Enthusiastic about Bioinformatics and Molecular Biology | Eager to learn, grow, & contribute to impactful research
-Unlock the Power of 16S Metagenomics- "Transform your research with our state-of-the-art 16S NGS sequencing services! Get precise, high-throughput microbial profiling for your projects. Contact us today to learn more. #16SNGS #Microbiome #Biotech #Research"
To view or add a comment, sign in
-
Genomics Market worth $83.1 billion by 2028 Download PDF Brochure:-https://lnkd.in/dY2hKzvB The global genomics market in terms of revenue was estimated to be worth $46.2 billion in 2023 and is poised to reach $83.1 billion by 2028, growing at a CAGR of 12.4% from 2023 to 2028. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Illumina, Thermo Fisher Scientific, Danaher Corporation QIAGEN Agilent Technologies, PerkinElmer Wohlfahrtsstiftung der F. Hoffmann-La Roche AG Bio-Rad Laboratories, Eurofins Scientific Finland Oy PACIFIC BIOSCIENCES OF CALIF Oxford Nanopore Technologies Abbott Takara Bio USA, Inc. BGI Group Eppendorf Merck New England Biolabs Promega Corporation Creative Biogene Novogene 23andMe, 10x Genomics Ultima Genomics, Freenome Holdings Inc, Helix Polaris Genomics Personalis, Inc. Myriad Genetics, Quest Diagnostics Phalanx Biotech Group genomiQa Pty Ltd. #genomics #precisionmedicine #genetics #bioinformatics #personalizedmedicine
To view or add a comment, sign in
-
Attending WRIB next week? Schedule a meeting with our scientific experts to learn how we can partner on your drug development journey. Sign up here to have an expert reach out to you to set up a meeting: https://bit.ly/3TSxdyc #WRIB #bioanalysis #spatialbiology #spatialomics #oligo
To view or add a comment, sign in
-
Attending #WRIB? Schedule a meeting with our scientific experts to learn how we can partner on your drug development journey. Sign up here to have an expert reach out to you to set up a meeting: https://lnkd.in/evjZkuDX #WRIB #bioanalysis #spatialbiology #spatialomics #oligo
To view or add a comment, sign in
-
Genomics Market worth $83.1 billion by 2028 Download PDF Brochure:-https://lnkd.in/dTSsGfZg The global genomics market in terms of revenue was estimated to be worth $46.2 billion in 2023 and is poised to reach $83.1 billion by 2028, growing at a CAGR of 12.4% from 2023 to 2028. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Illumina, Thermo Fisher Scientific, Danaher Corporation QIAGEN Agilent Technologies, PerkinElmer Wohlfahrtsstiftung der F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Eurofins Scientific Finland Oy PACIFIC BIOSCIENCES OF CALIF Oxford Nanopore Technologies Abbott Takara Bio Inc. BGI Group Eppendorf Merck New England Biolabs Promega Corporation Creative Biogene Novogene., 23andMe, 10x Genomics Ultima Genomics, Freenome Holdings Inc, Helix Polaris Genomics Personalis, Inc. Myriad Genetics, Quest Diagnostics Phalanx Biotech Group genomiQa Pty Ltd. #genomics #genetics #precisionmedicine #bioinformatics #genomicresearch
To view or add a comment, sign in
-
𝐆𝐞𝐧𝐨𝐦𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐨𝐫𝐭𝐡 $83.1 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2028 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞:-https://lnkd.in/dGdb-hNb The global genomics market in terms of revenue was estimated to be worth $46.2 billion in 2023 and is poised to reach $83.1 billion by 2028, growing at a CAGR of 12.4% from 2023 to 2028. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Illumina, Thermo Fisher Scientific, Danaher Corporation QIAGEN Agilent Technologies, PerkinElmer. Wohlfahrtsstiftung der F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Eurofins Scientific Finland Oy PACIFIC BIOSCIENCES OF CALIF Oxford Nanopore Technologies Abbott Takara Bio Inc. BGI Group Eppendorf Merck New England Biolabs Promega Corporation Creative Biogene Novogene 23andMe, 10x Genomics Ultima Genomics, Freenome Holdings Inc, Helix Polaris Genomics Personalis, Inc. Myriad Genetics, Quest Diagnostics Phalanx Biotech Group genomiQa Pty Ltd. 𝐎𝐭𝐡𝐞𝐫 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐭𝐡𝐚𝐭 𝐚𝐫𝐞 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐠𝐥𝐨𝐛𝐚𝐥𝐥𝐲 Luminex Macrogen Inc. GeneWize GenScript Twist Bioscience Synthego Corporation Ginkgo Bioworks, Inc. Lucigen Corp. Integrated DNA Technologies #genomics #ngs #biotechnology #precisionmedicine
To view or add a comment, sign in
-
Attending WRIB? Schedule a meeting with our scientific experts to learn how we can partner on your drug development journey. Sign up here to have an expert reach out to you to set up a meeting: https://bit.ly/3TSxdyc #WRIB #bioanalysis #spatialbiology #spatialomics #oligo
To view or add a comment, sign in
-
Head of Bioinformatics, Antibody Engineering and Optimization, Novel ADCs and PROTACs design, Cheminformatics, DeNovo, SBDD, LBDD, Structural Biology, Machine learning, AlpfaFold, Molecular Modeling, 25+ US Patents
Recently, I read two papers on lymphatic filariasis (LF) discussing Cofactor-independent phosphoglycerate mutase (iPGM) as a potential drug target for LF, published in Oxford Academy-2024 (PMID:37481257) and Bentham Publications-2023 (PMID:31244425). I'm glad to have discovered this back in 2015. Here are some insights from my original article if you're interested: https://lnkd.in/eTdnyXs3. We delved into the structural stability of Wb-iPGM through molecular dynamics simulations, shedding light on its interaction with cofactors 3-phosphoglycerate (3PGA) and Mn2+ ions. Notably, we unveiled domain motions and the catalytic significance of Mn2+ ions, offering insights crucial for drug development. #LymphaticFilariasis #DrugDiscovery #ResearchInsights #Structuralbiology #simulations #bioinformatics #computationalbiology
To view or add a comment, sign in
-
Confronted with the complexities of samples? The solution is closer than you think—join us tomorrow! MOBILion Systems, in partnership with Agilent Technologies invites you to a pivotal lunch symposium at the 55th Annual DGMS Conference. Be there on Monday, March 11th, 2024, 12-1 PM, Lecture Hall 16, Freising, Germany. Jennifer Krone, PhD., Director of Strategic Partnerships at MOBILion, will showcase the MOBIE platform's transformative power: unmatched resolution, greater throughput, and superior reproducibility. Don't miss this chance to see how we're reshaping analytical science together. https://hubs.ly/Q02ndg1b0 Technical University of Munich #DGMS2024 #MOBILion #agilent #MassSpec #ProteinCharacterization #HRIMAdvancements #TeamMassSpec #bioanalytical #MassSpectrometry #SeparationSciences #SLIM #biopharma #biotherapeutics #Glycans #Isomerome #HRIM #molecules #peptides #oligos #antibodies #proteomics #metabolomics #Science #Research #MS #Bioinformatics #lipidomics #LCMS #HPLC
To view or add a comment, sign in
-
🌐 🗺 Our list of the 14 Must-Attend Genomic and Biotechnology Conferences and Courses for 2024. There is no need to endlessly search, we've researched for you. Take a look here https://lnkd.in/dQWiDCir #ACMG2024, #ESHG2024 #ASHG2024 #LondonCalling2024 #genetics #raredisease
To view or add a comment, sign in